<DOC>
	<DOCNO>NCT01959230</DOCNO>
	<brief_summary>To compare efficacy safety brimonidine tartrate ophthalmic solution 0.025 % vehicle treat ocular redness population adult geriatric participant ocular redness .</brief_summary>
	<brief_title>Efficacy Safety Brimonidine Tartrate Ophthalmic Solution Adult Geriatric Subjects With Ocular Redness .</brief_title>
	<detailed_description />
	<mesh_term>Hyperemia</mesh_term>
	<mesh_term>Erythema</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>At least 18 year age . Have history redness relief drop use , express desire use drop redness relief , within last 6 month . Have ocular health within normal limit include calculate bestcorrected visual acuity 0.3 logMAR good eye , measure use ETDRS chart . Any ocular/systemic health problem . Use disallowed medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Ocular redness</keyword>
</DOC>